Our aim was to compare the biodistribution of free IGF-1, IGF-1/IGFBP-3, and IGF-1/NP complex in selected organs over the time in Cln1-/- mouse model if IGF-1 could be used as a potential drug to treat INCL. The gene discussed is IGF1; the disease is infantile neuronal ceroid lipofuscinosis.